208 related articles for article (PubMed ID: 37287062)
1. Imaging features based on CT and MRI for predicting prognosis of patients with intrahepatic cholangiocarcinoma: a single-center study and meta-analysis.
Sun D; Xu Z; Cao S; Wu H; Lu M; Xu Q; Wang K; Ji G
Cancer Imaging; 2023 Jun; 23(1):56. PubMed ID: 37287062
[TBL] [Abstract][Full Text] [Related]
2. CT-based clinico-radiological nomograms for prognosis prediction in patients with intrahepatic mass-forming cholangiocarcinoma: a multi-institutional study.
Jiao CY; Zhang H; Ji GW; Xu Q; Lu M; Zhang B; Yang Y; Wang XH; Li XC
Eur Radiol; 2022 Dec; 32(12):8326-8338. PubMed ID: 35708837
[TBL] [Abstract][Full Text] [Related]
3. Combined arterial and delayed enhancement patterns of MRI assist in prognostic prediction for intrahepatic mass-forming cholangiocarcinoma (IMCC).
Jin KP; Sheng RF; Yang C; Zeng MS
Abdom Radiol (NY); 2022 Feb; 47(2):640-650. PubMed ID: 34820689
[TBL] [Abstract][Full Text] [Related]
4. Mass-forming intrahepatic cholangiocarcinoma with marked enhancement on arterial-phase computed tomography reflects favorable surgical outcomes.
Ariizumi S; Kotera Y; Takahashi Y; Katagiri S; Chen IP; Ota T; Yamamoto M
J Surg Oncol; 2011 Aug; 104(2):130-9. PubMed ID: 21448898
[TBL] [Abstract][Full Text] [Related]
5. Risk stratification for overall survival and recurrence-free survival after R0 resection for solitary intrahepatic mass-forming cholangiocarcinoma based on preoperative MRI and clinical features.
Chen S; Wan L; Zhao R; Peng W; Liu X; Li L; Zhang H
Eur J Radiol; 2023 Dec; 169():111190. PubMed ID: 37979460
[TBL] [Abstract][Full Text] [Related]
6. Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma.
Asayama Y; Yoshimitsu K; Irie H; Tajima T; Nishie A; Hirakawa M; Nakayama T; Kakihara D; Taketomi A; Aishima S; Honda H
Radiology; 2006 Jan; 238(1):150-5. PubMed ID: 16304089
[TBL] [Abstract][Full Text] [Related]
7. Role of Central Hypo-enhancement in the Hepatic Arterial Phase of Dynamic Computed Tomography in Patients with Mass-Forming Intrahepatic Cholangiocarcinoma.
Teraoku H; Morine Y; Uyama N; Ikemoto T; Iwahashi S; Saito Y; Takasu C; Imura S; Harada M; Shimada M
World J Surg; 2020 Jul; 44(7):2350-2358. PubMed ID: 32152739
[TBL] [Abstract][Full Text] [Related]
8. Outcomes assessment in intrahepatic cholangiocarcinoma using qualitative and quantitative imaging features.
King MJ; Hectors S; Lee KM; Omidele O; Babb JS; Schwartz M; Tabrizian P; Taouli B; Lewis S
Cancer Imaging; 2020 Jul; 20(1):43. PubMed ID: 32620153
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
[TBL] [Abstract][Full Text] [Related]
10. Enhancement Patterns of Intrahepatic Cholangiocarcinoma on Contrast-Enhanced Ultrasound: Correlation with Clinicopathologic Findings and Prognosis.
Yuan M; Li R; Zhang Y; Yang L; Zhang X; Tang C; Guo D
Ultrasound Med Biol; 2019 Jan; 45(1):26-34. PubMed ID: 30292461
[TBL] [Abstract][Full Text] [Related]
11. MRI features predict microvascular invasion in intrahepatic cholangiocarcinoma.
Ma X; Liu L; Fang J; Rao S; Lv L; Zeng M; Shi Y; Yang C
Cancer Imaging; 2020 Jun; 20(1):40. PubMed ID: 32576283
[TBL] [Abstract][Full Text] [Related]
12. Preoperative prediction of postsurgical outcomes in mass-forming intrahepatic cholangiocarcinoma based on clinical, radiologic, and radiomics features.
Park HJ; Park B; Park SY; Choi SH; Rhee H; Park JH; Cho ES; Yeom SK; Park S; Park MS; Lee SS
Eur Radiol; 2021 Nov; 31(11):8638-8648. PubMed ID: 33890153
[TBL] [Abstract][Full Text] [Related]
13. Radiomics-Based Preoperative Prediction of Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma Using Contrast-Enhanced Computed Tomography.
Zhang S; Huang S; He W; Wei J; Huo L; Jia N; Lin J; Tang Z; Yuan Y; Tian J; Shen F; Li J
Ann Surg Oncol; 2022 Oct; 29(11):6786-6799. PubMed ID: 35789309
[TBL] [Abstract][Full Text] [Related]
14. Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated with tumor biomarkers and prognosis.
Zhou C; Wang Y; Ma L; Qian X; Yang C; Zeng M
Eur Radiol; 2022 Jan; 32(1):78-88. PubMed ID: 34279688
[TBL] [Abstract][Full Text] [Related]
15. Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis.
Mavros MN; Economopoulos KP; Alexiou VG; Pawlik TM
JAMA Surg; 2014 Jun; 149(6):565-74. PubMed ID: 24718873
[TBL] [Abstract][Full Text] [Related]
16. Impact and Prediction of Lymph Node Involvement in Patients with Intrahepatic Cholangiocarcinoma After Curative Resection.
Harada N; Yoshizumi T; Yamashita YI; Soejima Y; Ikegami T; Harimoto N; Itoh S; Maehara Y
Anticancer Res; 2017 Jul; 37(7):3763-3769. PubMed ID: 28668872
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
Zhao YJ; Chen WX; Wu DS; Zhang WY; Zheng LR
Abdom Radiol (NY); 2016 May; 41(5):978-89. PubMed ID: 27193795
[TBL] [Abstract][Full Text] [Related]
18. A proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance.
Rhee H; Kim MJ; Park YN; An C
Eur Radiol; 2019 Jun; 29(6):3111-3121. PubMed ID: 30560357
[TBL] [Abstract][Full Text] [Related]
19. MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma.
Sammon J; Fischer S; Menezes R; Hosseini-Nik H; Lewis S; Taouli B; Jhaveri K
Cancer Imaging; 2018 Feb; 18(1):8. PubMed ID: 29486800
[TBL] [Abstract][Full Text] [Related]
20. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
Ichikawa S; Isoda H; Shimizu T; Tamada D; Taura K; Togashi K; Onishi H; Motosugi U
Eur Radiol; 2020 Nov; 30(11):5992-6002. PubMed ID: 32500195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
